Science Explorer Interactive view Map
Company · Bourg-la-Reine · France

Cemka-Eval (France)

In research, Cemka-Eval (France) stands highest in Medicine (#12,443 of 17,978 worldwide) and Health Sciences (#15,173 of 20,462 worldwide), over all time.

cemka.frROR OpenAlex
World rank, all time
#36,685
of 42,892
Rank in France
#1,993
of 2,321
Research works
274
▲ 10% vs 2013–17
Citations
2.9k
10.6 per fractional work
Top-10% rate
6.1%
record average 16.5%
Open access
28%
world 28%

What is Cemka-Eval (France) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #12,443 of 17,978 10.5%166
Health SciencesDomain #15,173 of 20,462 11.2%204

Each strip is that field’s whole ranked pool, with the notch where Cemka-Eval (France) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.64× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 2.11× its world share, 1 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 3.31× its world share, 1 worksPharmacology, Toxico…Computer Science: 0.04× its world share, 0 worksComputer ScienceEngineering: 0.14× its world share, 1 worksEngineeringEnvironmental Science: 0.01× its world share, 0 worksEnvironmental ScienceMathematics: 0.42× its world share, 0 worksMathematicsPhysics and Astronomy: 0.46× its world share, 0 worksPhysics and AstronomyHealth Professions: 4.12× its world share, 6 worksHealth ProfessionsMedicine: 2.75× its world share, 27 worksMedicineNursing: 0.12× its world share, 0 worksNursingBusiness, Management and Accounting: 0.05× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 10.73× its world share, 12 worksEconomics, Econometr…Psychology: 0.11× its world share, 0 worksPsychologySocial Sciences: 0.16× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 10.7×. Every wedge is a field page.

Who are the top researchers at Cemka-Eval (France)?

Ranked on the composite score, G Berdeaux, Francis Fagnani and A Lafuma lead among researchers whose main affiliation is Cemka-Eval (France).

  1. 1 G Berdeaux France · #598,141 worldwide 38 citations · 35 works
  2. 2 Francis Fagnani France · #864,280 worldwide 27 citations · 38 works
  3. 3 A Lafuma France · #886,691 worldwide 45 citations · 47 works
  4. 4 Corinne Emery France · #894,735 worldwide 18 citations · 27 works
  5. 5 C. Godard France · #1,052,238 worldwide 11 citations · 16 works
  6. 6 B. Detournay France · #1,149,486 worldwide 29 citations · 53 works
  7. 7 S. Bouée France · #1,154,227 worldwide 21 citations · 40 works
  8. 8 Camille Nevoret France · #1,619,964 worldwide 4 citations · 18 works
All ranked researchers at Cemka-Eval (France)

Which keywords describe research at Cemka-Eval (France)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Primary Care, Social Determinants of Health, Digital Health, Healthcare Policy and Inequalities.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Quality of Life8▲ 10×10 topics
  2. Cost-effectiveness Analysis6▲ 139×1 topic
  3. Epidemiology6▲ 3.0×33 topics
  4. Health Utility Measures6▲ 139×1 topic
  5. Primary Care5▲ 27×4 topics
  6. Public Health5▲ 6.5×7 topics
  7. Digital Health5▲ 78×2 topics
  8. Social Determinants of Health5▲ 40×3 topics
  9. Healthcare Policy4▲ 92×1 topic
  10. Inequalities4▲ 250×1 topic
  11. Treatment4▲ 5.8×12 topics
  12. Autoantibodies3▲ 26×6 topics
  13. Drug Development Costs3▲ 227×1 topic
  14. Generic Drugs3▲ 227×1 topic
  15. Neurological Disorders2▲ 8.3×3 topics
  16. Cardiovascular Disease2▲ 3.4×9 topics
  17. Headache Disorders2▲ 164×1 topic
  18. Migraine2▲ 96×1 topic
  19. Diagnosis2▲ 4.0×8 topics
  20. Innovation Policy2▲ 36×2 topics
  21. Glycemic Control2▲ 21×4 topics
  22. Diabetes2▲ 6.5×6 topics
  23. Private R&D2▲ 162×1 topic
  24. R&D Subsidies2▲ 162×1 topic
  25. Antiphospholipid Syndrome1▲ 58×1 topic
  26. Immune Response1▲ 4.8×6 topics
  27. Systemic Lupus Erythematosus1▲ 52×1 topic
  28. Immunosuppressive Therapy1▲ 13×4 topics
  29. Cognitive Impairment1▲ 9.3×4 topics
  30. Insulin Therapy1▲ 19×3 topics
  31. Cancer Incidence1▲ 16×3 topics
  32. Diagnostic Criteria1▲ 9.4×2 topics
  33. Antiviral Therapy1▲ 20×3 topics
  34. Contraception1▲ 75×1 topic
  35. Cost of Care1▲ 67×1 topic
  36. Endothelial Dysfunction1▲ 8.5×2 topics
  37. Fibrosis1▲ 11×3 topics
  38. Financial Toxicity1▲ 67×1 topic
  39. Leak Detection1▲ 74×1 topic
  40. Type 1 Diabetes1▲ 23×2 topics

Which research topics does Cemka-Eval (France) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Healthcare Systems and Practices, Pharmaceutical Economics and Policy and Migraine and Headache Studies.

Health Systems, Economic…6Health Systems, Economic Evaluations, Quality of Life: 6 fractional worksHealthcare Systems and Practices: 4 fractional worksPharmaceutical Economics and Policy: 3 fractional worksMigraine and Headache St…2Migraine and Headache Studies: 2 fractional worksInnovation Policy and R&D2Innovation Policy and R&D: 2 fractional worksSystemic Lupus Erythemat…1Systemic Lupus Erythematosus Research: 1 fractional worksEconomic and Financial Impacts of Cancer: 1 fractional worksWater Systems and Optimization: 1 fractional worksReproductive Health and Contraception: 1 fractional worksHealth and Medical Research Impacts: 1 fractional works
Economics and EconometricsGeneral Health ProfessionsPsychiatry and Mental healthRheumatology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 6 works
  2. 2 Healthcare Systems and Practices General Health Professions 4 works
  3. 3 Pharmaceutical Economics and Policy Economics and Econometrics 3 works
  4. 4 Migraine and Headache Studies Psychiatry and Mental health 2 works
  5. 5 Innovation Policy and R&D Economics and Econometrics 2 works
  6. 6 Systemic Lupus Erythematosus Research Rheumatology 1 works
  7. 7 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
  8. 8 Water Systems and Optimization Civil and Structural Engineering 1 works
  9. 9 Reproductive Health and Contraception Public Health, Environmental and Occupational Health 1 works
  10. 10 Health and Medical Research Impacts Public Health, Environmental and Occupational Health 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available28.5%not open71.5%

World: 28% of research is openly available.

with international co-authors14.8%domestic only85.2%

World: 19% is written across borders.

How has Cemka-Eval (France)'s research output changed?

Output in 2018–2022 was 10% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.